| 11964961 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2024-04-23 |
| 11014909 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2021-05-25 |
| 10858373 |
Heterocyclic spiro compounds as MAGL inhibitors |
Michael Aaron Brodney, Christopher Ryan Butler, Laura Ann McAllister, Christopher John Helal, Patrick Robert Verhoest |
2020-12-08 |
| 10723711 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors |
Christopher Ryan Butler, Laura Ann McAllister, Elizabeth Mary Beck, Michael Aaron Brodney, Adam Matthew Gilbert +6 more |
2020-07-28 |
| 10696658 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2020-06-30 |
| 10626125 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors |
Michael Aaron Brodney, Christopher Ryan Butler, Laura Ann McAllister, Christopher John Helal, Patrick Robert Verhoest |
2020-04-21 |
| 10428034 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors |
Christopher Ryan Butler, Laura Ann McAllister, Elizabeth Mary Beck, Michael Aaron Brodney, Adam Matthew Gilbert +6 more |
2019-10-01 |
| 10421744 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2019-09-24 |
| 10329308 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors |
Michael Aaron Brodney, Christopher Ryan Butler, Laura Ann McAllister, Christopher John Helal, Patrick Robert Verhoest |
2019-06-25 |
| 10093655 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2018-10-09 |
| 10077272 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov +4 more |
2018-09-18 |
| 9868744 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov +4 more |
2018-01-16 |
| 9845301 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors |
Christopher Ryan Butler, Laura Ann McAllister, Elizabeth Mary Beck, Michael Aaron Brodney, Adam Matthew Gilbert +6 more |
2017-12-19 |
| 9822097 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2017-11-21 |
| 9745317 |
Heterocyclic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov +2 more |
2017-08-29 |
| 9617275 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Jotham Wadsworth Coe, John Arthur Allen, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov +9 more |
2017-04-11 |
| 9527843 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Scot Richard Mente +3 more |
2016-12-27 |
| 9527831 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2016-12-27 |
| 9139561 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2015-09-22 |
| 9133190 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Scot Richard Mente +3 more |
2015-09-15 |
| 9107923 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2015-08-18 |
| 8822494 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Scot Richard Mente +3 more |
2014-09-02 |
| 7326705 |
Heterocyclic sodium/proton exchange inhibitors and method |
Saleem Ahmad, Shung C. Wu, Khehyong Ngu, Karnail Atwal, David S. Weinstein |
2008-02-05 |
| 7138395 |
Interleukin-1β converting enzyme inhibitors |
Michael Christopher Laufersweiler, Yili Wang, Kofi Abeka Oppong, David Lindsey Soper, John August Wos +2 more |
2006-11-21 |
| 7041696 |
Interleukin-1β converting enzyme inhibitors |
John August Wos, David Lindsey Soper, Yili Wang, Kofi Abeka Oppong, Michael Christopher Laufersweiler +3 more |
2006-05-09 |
